Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:alternativeTo |
alum adjuvant
|
| gptkbp:approvalYear |
1997
|
| gptkbp:approvedBy |
gptkb:Europe
gptkb:United_States |
| gptkbp:compatibleWith |
live vaccines
|
| gptkbp:component |
gptkb:polysorbate_80
gptkb:squalene citrate buffer sorbitan trioleate |
| gptkbp:composition |
squalene oil-in-water emulsion
|
| gptkbp:developedBy |
gptkb:Novartis
|
| https://www.w3.org/2000/01/rdf-schema#label |
MF59 adjuvant
|
| gptkbp:improves |
cell-mediated immunity
antibody response |
| gptkbp:indication |
influenza prevention
|
| gptkbp:mechanismOfAction |
enhances immune response
|
| gptkbp:regulates |
licensed adjuvant
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:safetyProfile |
well-tolerated
|
| gptkbp:storage |
refrigerated
|
| gptkbp:usedIn |
gptkb:Fluad_vaccine
influenza vaccines elderly population pediatric population |
| gptkbp:bfsParent |
gptkb:Fluad
|
| gptkbp:bfsLayer |
6
|